Skip to content

NRSN — Neurosense Therapeutics Ltd Institutional Holders · Q2 2026

Who owns Neurosense Therapeutics Ltd (NRSN)? 15 institutions reported holding $285,749 in SEC 13F filings for Q2 2026 (period ended 2026-06-30). Largest holders: UBS Group AG ($78,218), Independent Advisor Alliance ($72,000), Yorkville Advisors Global, LP ($56,160).

RankInstitutionValueSharesChange
1UBS Group AG$78,218108,636Added
2Independent Advisor Alliance$72,000100,000Added
3Yorkville Advisors Global, LP$56,16078,000Hold
4COMMONWEALTH EQUITY SERVICES, LLC$16,40022,775Hold
5PNC Financial Services Group, Inc.$15,22821,150Hold
6Pathstone Holdings, LLC$11,90016,528Hold
7GEODE CAPITAL MANAGEMENT, LLC$11,42615,870Hold
8XTX Topco Ltd$8,26111,473New
9Creative Planning$8,21511,410Trimmed
10HRT FINANCIAL LP$7,00010,515New
11JONES FINANCIAL COMPANIES LLLP$7571,000Hold
12SBI Securities Co., Ltd.$184255Trimmed
13TWO SIGMA INVESTMENTS, LP$00Exited
14MEITAV INVESTMENT HOUSE LTD$00Exited
15JANE STREET GROUP, LLC$00Exited

Source: SEC Form 13F filings · as of 2026-06-30